Click and see the interview of ERN BOND member, Andrè Travessa, for Newspharma about “Bone Dysplasias 2024: Symposium on Bone Dysplasias”, a congress dedicated to updating knowledge on bone dysplasias, which took place in May this year.
This symposium had over 100 participants and was organised by ULS Santa Maria and Assoc. Portuguesa Osteogenesis Imperfecta, with the support of BioMarin Pharmaceutical Inc, ERN BOND, Ultragenyx, Kyowa Kirin International plc and SYNLAB Portugal, among many other scientific and institutional sponsors.
ERN-BOND is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are Funded by the European Commission. For more information about the ERNs and the EU health strategy, please visit ec.europa.eu/health/ern
Funded by the European Union
ERN BOND Specific Grant Agreement no. 101157116
Coordinating Center
Istituto Ortopedico Rizzoli
via G.C.Pupilli, 1 – 40136 Bologna – Italy
The contents of this website represents the views of the network and
is its sole responsibility; and do not necessarily reflect the opinion of the European Union
Co-funded by the European Union
ERN BOND Specific Grant Agreement no. 101157116
Coordinating Center
Istituto Ortopedico Rizzoli
via G.C.Pupilli, 1 – 40136 Bologna – Italy
The contents of this website represents the views of the network and is its sole responsibility; and do not necessarily reflect the opinion of the European Union
